Omega Healthcare Investors Inc OHI
Institutional shares held
222 Million
2.14M
calls
1.69M
puts
Total value of holdings
$9.76B
$94.1M
calls
$74.3M
puts
Market Cap
$10.3B
234,111,008
Shares Out.
Institutional ownership
94.81%
# of Institutions
765
We take great care to ensure that the data presented and summarized in this overview for OMEGA HEALTHCARE INVESTORS INC is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Top Institutions Holding OHI
View all-
Vanguard Group Inc Valley Forge, PA42.2MShares$1.85 Billion0.03% of portfolio
-
Black Rock Inc. New York, NY30.1MShares$1.32 Billion0.02% of portfolio
-
Cohen & Steers, Inc. New York, NY17.1MShares$753 Million1.3% of portfolio
-
State Street Corp Boston, MA14.6MShares$643 Million0.02% of portfolio
-
Geode Capital Management, LLC Boston, MA7.78MShares$342 Million0.02% of portfolio
-
Invesco Ltd. Atlanta, GA4.94MShares$217 Million0.03% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA4.29MShares$189 Million0.03% of portfolio
-
Dimensional Fund Advisors LP Austin, TX4.21MShares$185 Million0.04% of portfolio
-
Jpmorgan Chase & CO New York, NY3.42MShares$150 Million0.01% of portfolio
-
Centersquare Investment Management LLC Plymouth Meeting, PA3.3MShares$145 Million1.44% of portfolio
Latest Institutional Activity in OHI
Top Purchases
Top Sells
About OHI
Omega is a real estate investment trust that invests in the long-term healthcare industry, primarily in skilled nursing and assisted living facilities. Its portfolio of assets is operated by a diverse group of healthcare companies, predominantly in a triple-net lease structure. The assets span all regions within the US, as well as in the UK.
Insider Transactions at OHI
Insider Transaction List
View all| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Nov 06
2025
|
Vikas Gupta Chief Investment Officer |
BUY
Open market or private purchase
|
Direct |
11,500
+45.5%
|
$483,000
$42.97 P/Share
|
|
Nov 05
2025
|
C Taylor Pickett CHIEF EXECUTIVE OFFICER |
BUY
Open market or private purchase
|
Indirect |
20,000
+50.0%
|
$860,000
$43.14 P/Share
|
|
Oct 01
2025
|
Neal Ballew CHIEF ACCOUNTING OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
17
-0.4%
|
$714
$42.22 P/Share
|
|
Oct 01
2025
|
Neal Ballew CHIEF ACCOUNTING OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
201
+4.56%
|
$6,231
$31.16 P/Share
|
|
Aug 26
2025
|
Robert O Stephenson CHIEF FINANCIAL OFFICER |
SELL
Bona fide gift
|
Direct |
800
-0.44%
|
-
|
|
Aug 08
2025
|
Lisa Egbuonu Davis |
SELL
Open market or private sale
|
Direct |
2,500
-5.96%
|
$100,000
$40.16 P/Share
|
|
Jul 01
2025
|
Neal Ballew CHIEF ACCOUNTING OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
9
-0.22%
|
$324
$36.65 P/Share
|
|
Jul 01
2025
|
Neal Ballew CHIEF ACCOUNTING OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
200
+4.75%
|
$6,200
$31.16 P/Share
|
|
Jun 06
2025
|
Kevin J Jacobs |
BUY
Grant, award, or other acquisition
|
Direct |
7,114
+14.84%
|
$263,218
$37.6 P/Share
|
|
Jun 06
2025
|
Lisa Egbuonu Davis |
BUY
Grant, award, or other acquisition
|
Direct |
4,388
+17.18%
|
$162,356
$37.6 P/Share
|
|
Jun 06
2025
|
Burke W Whitman |
BUY
Grant, award, or other acquisition
|
Direct |
4,388
+9.04%
|
$162,356
$37.6 P/Share
|
|
Apr 01
2025
|
Neal Ballew CHIEF ACCOUNTING OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
9
-0.24%
|
$342
$38.08 P/Share
|
|
Apr 01
2025
|
Neal Ballew CHIEF ACCOUNTING OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
195
+4.86%
|
$6,240
$32.18 P/Share
|
|
Jan 01
2025
|
Vikas Gupta Chief Investment Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
10
-0.44%
|
$370
$37.85 P/Share
|
|
Jan 01
2025
|
Vikas Gupta Chief Investment Officer |
BUY
Grant, award, or other acquisition
|
Direct |
192
+7.76%
|
$6,144
$32.18 P/Share
|
|
Jan 01
2025
|
Matthew Paul Gourmand President |
SELL
Payment of exercise price or tax liability
|
Direct |
9
-0.84%
|
$333
$37.85 P/Share
|
|
Jan 01
2025
|
Matthew Paul Gourmand President |
BUY
Grant, award, or other acquisition
|
Direct |
174
+13.92%
|
$5,568
$32.18 P/Share
|
|
Jan 01
2025
|
Neal Ballew CHIEF ACCOUNTING OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
10
-0.28%
|
$370
$37.85 P/Share
|
|
Jan 01
2025
|
Neal Ballew CHIEF ACCOUNTING OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
193
+5.04%
|
$6,176
$32.18 P/Share
|
|
Oct 01
2024
|
Neal Ballew CHIEF ACCOUNTING OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
19
-0.55%
|
$760
$40.7 P/Share
|
Last 12 Months Summary
Buy / Acquisition
48.5K
Shares
From
8
Insiders
| Grant, award, or other acquisition | 17K shares |
|---|---|
| Open market or private purchase | 31.5K shares |
Sell / Disposition
3.36K
Shares
From
5
Insiders
| Payment of exercise price or tax liability | 64 shares |
|---|---|
| Open market or private sale | 2.5K shares |
| Bona fide gift | 800 shares |